Despite rapid advances in genome and exome sequencing, many individuals with rare diseases remain undiagnosed. In a ...

Despite rapid advances in genome and exome sequencing, many individuals with rare diseases remain undiagnosed. In a ...

Discover how rare genetic variants and common polygenic risk scores independently influence survival in idiopathic pulmonary ...

Find out how genome sequencing has emerged and what the future holds for one of biotech's most important tools.

The development of second tumors is influenced by several factors. These include the type and intensity of treatment received ...

MyOme, a leading whole-genome analysis and polygenic risk modeling (PRS) company, announced that it has joined The Partner Collective® by Collective Health®— a digital health partner hub that helps ...

Collaboration leverages HiFi's unique ability to reveal hidden variants, bringing a new level of precision to early life ...

Over the last several years, whole-genome sequencing (WGS) has become an essential tool for helping hospitals identify outbreaks of healthcare-associated bacterial infections. But a new study suggests ...

Two life scientists at Gyeongsang National University and a geneticist from the National Institutes of Health, in the U.S.

today announced a strategic collaboration to implement PacBio HiFi whole genome sequencing (WGS) as part of a newborn screening research program. This marks the first initiative in Asia Pacific to ...